A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell · Leukemia, Chronic Lymphocytic · Small-Cell Lymphoma · Lymphoma, Small Lymphocytic · CLL · SLL
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Highlands Oncology Group ( Site 5405), Springdale, Arkansas, United States
MemorialCare Health System - Long Beach Medical Center ( Site 5421), Long Beach, California, United States
Memorial Hospital West ( Site 5410), Pembroke Pines, Florida, United States
Oregon Health and Science University ( Site 5425), Portland, Oregon, United States
Medical Oncology Associates, PS ( Site 5406), Spokane, Washington, United States
University of Wisconsin Hospital and Clinics-Carbone Cancer Center ( Site 5423), Madison, Wisconsin, United States
Instituto Alexander Fleming ( Site 1005), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Instituto de Investigaciones Clínicas Mar del Plata ( Site 1007), Mar del Plata, Buenos Aires, Argentina
Sanatorio Parque ( Site 1003), Rosario, Santa Fe Province, Argentina
Centro Medico Fleischer ( Site 1006), Buenos Aires, Argentina
Hospital Aleman-oncohematologic diseases ( Site 1001), Buenos Aires, Argentina
Royal Adelaide Hospital ( Site 1104), Adelaide, South Australia, Australia
Western Health-Sunshine & Footscray Hospitals-Cancer Services-Cancer Research ( Site 1103), Melbourne, Victoria, Australia
UZ Leuven-Hematology ( Site 1200), Leuven, Vlaams-Brabant, Belgium
ZAS Cadix ( Site 1203), Antwerp, Belgium
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO-Pesquisa Clinica ( Site 1308), São Paulo, Brazil
The Moncton Hospital ( Site 1414), Moncton, New Brunswick, Canada
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 1402), Greenfield Park, Quebec, Canada
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 1410), Sherbrooke, Quebec, Canada
Biocenter ( Site 1507), Concepción, Biobio, Chile
IC La Serena Research ( Site 1506), La Serena, Coquimbo Region, Chile
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 1509), Santiago, Region M. de Santiago, Chile
FALP-UIDO ( Site 1500), Santiago, Region M. de Santiago, Chile
Clínica Inmunocel ( Site 1511), Santiago, Region M. de Santiago, Chile
Fundación Valle del Lili ( Site 1703), Cali, Valle del Cauca Department, Colombia
Hopital Claude Huriez - CHU de Lille ( Site 2107), Lille, Nord, France
Centre Hospitalier Universitaire Estaing ( Site 2105), Clermont-Ferrand, Puy-de-Dome, France
CHD Vendee ( Site 2100), La Roche-sur-Yon, Vendee, France
Klinikum Mutterhaus der Borromäerinnen-Innere Medizin I ( Site 2203), Trier, Rhineland-Palatinate, Germany
Universitätsklinikum Leipzig-Medical Department I - Hematology and Celltherapy ( Site 2201), Leipzig, Saxony, Germany
Rambam Health Care Campus ( Site 2801), Haifa, Israel
Hadassah Medical Center-Hemato-Oncology ( Site 2812), Jerusalem, Israel
Sheba Medical Center-Hemato Oncology ( Site 2809), Ramat Gan, Israel
Sourasky Medical Center ( Site 2811), Tel Aviv, Israel
Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo ( Site 2906), Alessandria, Italy
Ospedale San Raffaele-Programma di Ricerca Strategica sulla LLC ( Site 2902), Milan, Italy
Arcispedale Santa Maria Nuova-Hematology ( Site 2900), Reggio Emilia, Italy
Centro de Infusion Superare ( Site 3314), Mexico City, Mexico City, Mexico
Health Pharma Professional Research S.A. de C.V: ( Site 3301), Mexico City, Mexico City, Mexico
Centro de Investigacion Clinica Chapultepec ( Site 3309), Morelia, Michoacán, Mexico
Auxilio Mutuo Cancer Center ( Site 3900), San Juan, Puerto Rico
Alberts Cellular Therapy. ( Site 4401), Pretoria, Gauteng, South Africa
Groote Schuur Hospital ( Site 4400), Cape Town, Western Cape, South Africa
Haemalife ( Site 4407), Kuilsriver, Western Cape, South Africa
Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 4601), L'Hospitalet Del Llobregat, Barcelona, Spain
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 4602), Pozuelo de Alarcón, Madrid, Spain
HOSPITAL CLINICO DE VALENCIA-HEMATOLOGY ( Site 4603), Valencia, Valenciana, Comunitat, Spain
Ege Universitesi Hastanesi ( Site 4902), Bornova, İzmir, Turkey (Türkiye)
Namik Kemal University Medical Faculty-Hematology ( Site 4912), Tekirdağ, Tekirdas, Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 4913), Ankara, Turkey (Türkiye)
Mega Medipol-Hematology ( Site 4904), Istanbul, Turkey (Türkiye)
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 4906), Istanbul, Turkey (Türkiye)
City Hospital, Nottingham University Hospitals-Hematology ( Site 5002), Nottingham, England, United Kingdom
University College London Hospital-Cancer Clinical Trials Unit ( Site 5001), London-Camden, London, City of, United Kingdom
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC